111 (NASDAQ:YI - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by stock analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.
111 Stock Up 5.0 %
Shares of NASDAQ:YI traded up $0.33 during trading on Friday, reaching $6.98. The stock had a trading volume of 40,779 shares, compared to its average volume of 51,776. The stock has a market cap of $59.69 million, a P/E ratio of -1.75 and a beta of 0.41. 111 has a fifty-two week low of $4.14 and a fifty-two week high of $15.80. The business has a fifty day moving average price of $6.48 and a 200-day moving average price of $7.69.
111 (NASDAQ:YI - Get Free Report) last posted its quarterly earnings data on Wednesday, November 27th. The company reported ($0.20) EPS for the quarter.
111 Company Profile
(
Get Free Report)
111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.
Read More
Before you consider 111, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 111 wasn't on the list.
While 111 currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
